I

Illimis Therapeutics

14 employees

Illimis Therapeutics is a science and technology company that develops treatment for degenerative brain and autoimmune diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Therapeutics
Pharmaceutical
Biopharma

Date founded

2021

Funding rounds raised

I

Illimis Therapeutics raised undisclosed on January 1, 2023

Investors: DAYLI Partners and Company K Partners

FAQ